Kyntra Bio (KYNB) Current Leases (2019 - 2024)

Kyntra Bio has disclosed Current Leases across 6 years of filings, most recently posting $1.3 million for Q3 2024.

• In Q3 2024, Current Leases fell 89.12% year-over-year to $1.3 million; the TTM figure through Sep 2024 stood at $1.3 million (down 89.12% YoY), while the FY2023 annual figure was $12.6 million, up 22.88% from the prior year.
• Current Leases came in at $1.3 million for Q3 2024 at Kyntra Bio, down from $15.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $15.5 million in Q2 2024 to a low of $1.3 million in Q3 2024.
• Average Current Leases over 5 years is $11.3 million, with a median of $11.5 million recorded in 2022.
• The largest YoY upside for Current Leases was 53.43% in 2024 against a maximum downside of 89.12% in 2024.
• Over 5 years, Current Leases stood at $12.3 million in 2020, then decreased by 11.24% to $10.9 million in 2021, then fell by 5.96% to $10.3 million in 2022, then grew by 22.88% to $12.6 million in 2023, then tumbled by 89.78% to $1.3 million in 2024.
• Per Business Quant data, the three most recent Current Leases figures were $1.3 million in Q3 2024, $15.5 million in Q2 2024, and $15.2 million in Q1 2024.